Related Subjects:
|Emphysema
|Chronic Bronchitis
|Chronic Obstructive Pulmonary Disease (COPD)
🌬️ COPD is largely preventable – 🚭 smoking cessation is the single most effective intervention.
🔑 Think COPD in people >35 with a smoking history and exertional breathlessness, chronic cough, sputum, wheeze, or recurrent “winter bronchitis”.
📉 Diagnosis is supported by post-bronchodilator spirometry: FEV1/FVC <0.7.
🚨 Acute Exacerbation (NICE-aligned)
- ABC assessment 🩺 – check SpO₂, RR, BP, pulse, ECG, and mental state; watch for exhaustion or confusion.
- Controlled oxygen 💨 – aim for the person’s target range; 88–92% if at risk of hypercapnic respiratory failure.
- Bronchodilators 💊 – nebulised salbutamol + ipratropium; use air-driven nebuliser if hypercapnic.
- Steroids 💉 – prednisolone 30 mg PO daily for 5 days; no taper for a short uncomplicated course.
- Antibiotics 🦠 – only if features suggest bacterial infection, following NICE antimicrobial guidance/local policy.
- ABG 🩸 – repeat if severe or deteriorating; rising PaCO₂ with acidosis = type 2 respiratory failure.
- NIV 😷 – if persistent hypercapnic acidosis despite optimal medical therapy.
- Supportive care – VTE prophylaxis, fluids/electrolytes, nutrition, and early senior/respiratory input.
💡 Exam tip: Confusion + rising PaCO₂ + acidosis = urgent NIV.
🎯 In COPD at risk of CO₂ retention, target sats are usually 88–92%, not 100%.
📖 Overview
- Usually smoking-related; includes features of emphysema and/or chronic bronchitis.
- Pathophysiology: chronic airway inflammation + mucus + small-airway narrowing + loss of elastic recoil → air trapping and hyperinflation.
- Advanced disease may lead to hypoxia, hypercapnia, pulmonary hypertension, and cor pulmonale.
⚠️ Risk Factors
- 🚬 Smoking (main cause)
- 🧬 Alpha-1 antitrypsin deficiency
- ⛏️ Occupational dusts/fumes and indoor biomass exposure
- 📈 Increasing age
🧑⚕️ Clinical Features
- Exertional dyspnoea, chronic cough, sputum, wheeze, fatigue.
- Barrel chest, prolonged expiration, pursed-lip breathing, reduced breath sounds.
- Late signs: cyanosis, oedema, raised JVP, cor pulmonale.
🔎 Investigations
- Spirometry: post-bronchodilator FEV1/FVC <0.7.
- CXR to look for hyperinflation and exclude other pathology.
- FBC for polycythaemia/anaemia.
- ABG if severe disease, low sats, or exacerbation.
- Alpha-1 antitrypsin if young, minimal smoking history, or family history.
💊 Chronic Management
- Smoking cessation, vaccinations, inhaler technique, and self-management advice.
- Pulmonary rehabilitation if functionally limited by breathlessness.
- SABA or SAMA for symptom relief.
- LABA+LAMA or LABA+ICS depending on whether there are asthmatic features/steroid responsiveness; escalate to triple therapy if needed.
- LTOT for selected stable patients with chronic severe hypoxaemia after formal assessment.
🧠 Exam Pearls
- COPD = clinical diagnosis supported by spirometry, not just a CXR label.
- Post-bronchodilator FEV1/FVC <0.7 is the key number.
- Prednisolone 30 mg for 5 days is the classic NICE exacerbation prescription.
- Most exacerbations are triggered by respiratory infection.
- Always check comorbidities: CVD, osteoporosis, anxiety/depression, lung cancer.
📚 References